Cargando…
Lentiviral vector-based therapy in head and neck cancer (Review)
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common neoplasm worldwide. Despite advances in multimodality treatments involving surgery, radiation and chemotherapy, the five-year survival rate has remained at ~50% for the past 35 years. Therefore, the early detection of recurrent o...
Autores principales: | UPRETI, DEEPAK, PATHAK, ALOK, KUNG, SAM K.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861563/ https://www.ncbi.nlm.nih.gov/pubmed/24348811 http://dx.doi.org/10.3892/ol.2013.1652 |
Ejemplares similares
-
Lentiviral Vectors for Ocular Gene Therapy
por: Arsenijevic, Yvan, et al.
Publicado: (2022) -
Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016) -
Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021) -
Lentiviral Vectors and Cystic Fibrosis Gene Therapy
por: Castellani, Stefano, et al.
Publicado: (2010) -
Development of lentiviral vectors for gene therapy of arthritis
por: Militello, M, et al.
Publicado: (2001)